PP
BSX icon

Palladium Partners’s Boston Scientific BSX Stock Holding History

Palladium Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$13.6M Buy
306,666
+24,004
+8% +$1.04M 0.6% 51
2021
Q4 		$12M Buy
282,662
+2,735
+1% +$115K 0.49% 56
2021
Q3 		$12.1M Buy
279,927
+19,735
+8% +$873K 0.55% 53
2021
Q2 		$11.1M Buy
260,192
+7,031
+3% +$296K 0.52% 54
2021
Q1 		$9.79M Buy
+253,161
New +$9.58M 0.49% 56

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Palladium Partners's BSX Position: Q1 2022 in Review

Palladium Partners increased its Boston Scientific (BSX) stake by 8.5% in Q1 2022, buying an estimated $1.04M and bringing the position to 306,666 shares worth $13.6M. The position accounts for 0.6% of the portfolio, ranked #51.

Palladium Partners first reported a position in BSX in Q1 2021 and has held it in 5 quarters since. 905 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Palladium Partners held 306,666 shares of Boston Scientific worth $13.6M as of Q1 2022.
  • Palladium Partners bought 24,004 Boston Scientific shares in Q1 2022, an estimated $1.04M.
  • Boston Scientific made up 0.6% of Palladium Partners's portfolio in Q1 2022, its #51 holding.
  • Palladium Partners first reported a position in Boston Scientific in Q1 2021 and has held it in 5 quarters since.
  • 905 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.